Back to TRVI
MORGAN STANLEY TRVI Position History
Trevi Therapeutics, Inc. • Healthcare
Quarters held
29
Latest value
$1.8M
Q2 2026
Peak value
$34.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $514K |
| Q3 2025 | $3.2M |
| Q3 2025 | $34.5M |
| Q3 2025 | $9 |
| Q3 2025 | $209K |
| Q3 2025 | $792K |
| Q3 2025 | $163K |
| Q4 2025 | $650K |
| Q4 2025 | $1.4M |
| Q4 2025 | $50 |
| Q4 2025 | $8.5M |
| Q4 2025 | $14 |
| Q4 2025 | $309K |
| Q4 2025 | $1.1M |
| Q4 2025 | $1.2M |
| Q1 2026 | $163K |
| Q1 2026 | $696K |
| Q1 2026 | $990 |
| Q1 2026 | $6.1M |
| Q1 2026 | $12 |
| Q1 2026 | $647K |
| Q1 2026 | $1.1M |
| Q2 2026 | $290K |
| Q2 2026 | $682K |
| Q2 2026 | $41K |
| Q2 2026 | $10.3M |
| Q2 2026 | $19 |
| Q2 2026 | $1.9M |
| Q2 2026 | $1.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $1.8M | 94.8K | — | — |
| Q2 2026 | $1.9M | 99.7K | — | — |
| Q2 2026 | $19 | 1 | — | — |
| Q2 2026 | $10.3M | 551.6K | — | — |
| Q2 2026 | $41K | 2.2K | — | — |
| Q2 2026 | $682K | 36.6K | — | — |
| Q2 2026 | $290K | 15.5K | — | — |
| Q1 2026 | $1.1M | 93.3K | — | — |
| Q1 2026 | $647K | 54.2K | — | — |
| Q1 2026 | $12 | 1 | — | — |
| Q1 2026 | $6.1M | 511.6K | — | — |
| Q1 2026 | $990 | 83 | — | — |
| Q1 2026 | $696K | 58.4K | — | — |
| Q1 2026 | $163K | 13.7K | — | — |
| Q4 2025 | $1.2M | 93.8K | — | — |
| Q4 2025 | $1.1M | 85.8K | — | — |
| Q4 2025 | $309K | 24.7K | — | — |
| Q4 2025 | $14 | 1 | — | — |
| Q4 2025 | $8.5M | 681.6K | — | — |
| Q4 2025 | $50 | 4 | — | — |
| Q4 2025 | $1.4M | 112.5K | — | — |
| Q4 2025 | $650K | 51.9K | — | — |
| Q3 2025 | $163K | 17.8K | — | — |
| Q3 2025 | $792K | 86.5K | — | — |
| Q3 2025 | $209K | 22.8K | — | — |
| Q3 2025 | $9 | 1 | — | — |
| Q3 2025 | $34.5M | 3.77M | — | — |
| Q3 2025 | $3.2M | 350.4K | — | — |
| Q3 2025 | $514K | 56.2K | — | — |